Şunu aradınız:: jaqbadhom (Maltaca - İngilizce)

pazjenti li jaqbadhom sturdament bħala reazzjoni avversa għandhom jevitaw li jsuqu karozzi jew jħaddmu magni.
patients who experience dizziness as an adverse reaction should avoid driving vehicles or using machines.

il-vaċċin għandu jiġi mogħti aktar tard lil persuni li jaqbadhom deni f’daqqa.
vaccination should be delayed in people who have a sudden fever.

il- vaċċin tal- prepandrix għandu jiġi mogħti aktar tard lil persuni li jaqbadhom deni f’ daqqa.
vaccination with prepandrix should be delayed in people who have a sudden fever.

tfal u adulti li qed jieħdu flixabi jista’ ikollhom riskju akbar li jaqbadhom limfoma jew xi tip ta’ kanċer ieħor.
children and adults taking flixabi may have an increased risk of developing lymphoma or another cancer.

il-vaċċin tal-prepandrix għandu jiġi mogħti aktar tard lil persuni li jaqbadhom deni qawwi jew infezzjoni f’daqqa.
vaccination with prepandrix should be delayed in people who have a severe fever or a sudden infection.

qabel ma tinbeda t- terapija b’ trudexa, pazjenti li qegħdin f’ riskju li jaqbadhom infezzjoni hbv għandhom jiġu eżaminati għal ott
patients at risk for hbv t uc

persuni li għandhom artrite rewmatika aktar serja u li ilhom ibatu minnha għal żmien twil jista ’ jkollhom riskju akbar mill- medja li jaqbadhom kanċer li jaffetwa is - ina
people with more serious rheumatoid arthritis that have had the disease for a lon long time may have a higher than average risk of getting a kind of cancer that affects the lymph system, called lymphoma.

f’każijiet rari, pazjenti fuq terapija bi prodotti mediċinali kontra l-ażma, inkluż omalizumab, jista’ jaqbadhom jew jiżviluppaw eżinofilja sistemika u vaskulite.
in rare cases, patients on therapy with anti-asthma medicinal products, including omalizumab, may present or develop systemic eosinophilia and vasculitis.

l- effetti ta ’ doża eċċessiva ta ’ gonal- f mhumiex magħrufa, madanakollu, wieħed jista ’ jistenna li l - pazjenti jaqbadhom is- sindromu ta ’ iperstimulazzjoni ta ’ l- ovarji, li hu deskritt f’ aktar dettall f ’ sezzjoni 4. 4.
the effects of an overdose of gonal-f are unknown, nevertheless one could expect ovarian hyperstimulation syndrome to occur, which is further described in section 4.4.